Collegium to Participate in Upcoming Investor Conferences
12 Nov 2024 //
GLOBENEWSWIRE
Collegium Appoints Vikram Karnani as Chief Executive Officer
07 Nov 2024 //
GLOBENEWSWIRE
Collegium Reports Record Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
Collegium To Report Q3 2024 Results On Nov 7
24 Oct 2024 //
GLOBENEWSWIRE
Collegium Completes Acquisition of Ironshore Therapeutics
04 Sep 2024 //
GLOBENEWSWIRE
Collegium To Participate In H.C. Wainwright Investment Conference
30 Aug 2024 //
GLOBENEWSWIRE
Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
28 Aug 2024 //
GLOBENEWSWIRE
Collegium Reports Second Quarter 2024 Financial Results
08 Aug 2024 //
GLOBENEWSWIRE
Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
29 Jul 2024 //
GLOBENEWSWIRE
Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
25 Jul 2024 //
GLOBENEWSWIRE
Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta
13 Jun 2024 //
GLOBENEWSWIRE
Collegium to Participate in Jefferies Global Healthcare Conference
29 May 2024 //
GLOBENEWSWIRE
Collegium Announces $35 Million Accelerated Share Repurchase Program
13 May 2024 //
GLOBENEWSWIRE
Collegium Announces CEO Transition
09 May 2024 //
GLOBENEWSWIRE
Collegium Reports First Quarter 2024 Financial Results
09 May 2024 //
GLOBENEWSWIRE
Collegium Authorized Generic Deal with Hikma for Nucynta®
29 Apr 2024 //
GLOBENEWSWIRE
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
25 Apr 2024 //
GLOBENEWSWIRE
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
03 Apr 2024 //
GLOBENEWSWIRE
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
22 Feb 2024 //
GLOBENEWSWIRE
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results
08 Feb 2024 //
GLOBENEWSWIRE
Collegium Provides 2024 Financial Guidance
03 Jan 2024 //
GLOBENEWSWIRE
Appeals Court Upholds PTAB™s Finding of Invalidity of Purdue™s 961 Patent
27 Nov 2023 //
GLOBENEWSWIRE
Collegium Announces $25 Million Accelerated Share Repurchase Program
09 Nov 2023 //
GLOBENEWSWIRE
Collegium to Participate in Upcoming Investor Conferences
08 Nov 2023 //
GLOBENEWSWIRE
Collegium Reports Third Quarter 2023 Financial Results
07 Nov 2023 //
GLOBENEWSWIRE
Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
24 Oct 2023 //
GLOBENEWSWIRE
Collegium Announces Extension of Nucynta Regulatory Exclusivity through 2026
24 Aug 2023 //
GLOBENEWSWIRE
Collegium Announces $50 Million Accelerated Share Repurchase Program
07 Aug 2023 //
GLOBENEWSWIRE
Here`s What Key Metrics Tell Us About Collegium Pharma (COLL) Q2 Earnings
04 Aug 2023 //
FINANCE YAHOO
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million
03 Aug 2023 //
PRESS RELEASE
Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023
20 Jul 2023 //
GLOBENEWSWIRE
Collegium to Participate in Jefferies Healthcare Conference
01 Jun 2023 //
GLOBENEWSWIRE
Collegium Reports First Quarter 2023 Financial Results
04 May 2023 //
GLOBENEWSWIRE
Collegium to Report First Quarter 2023 Financial Results on May 4, 2023
20 Apr 2023 //
GLOBENEWSWIRE
Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 //
GLOBENEWSWIRE
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report
22 Feb 2023 //
GLOBENEWSWIRE
Collegium Prices Upsized $210.0 Million Convertible Senior Notes Offering
07 Feb 2023 //
GLOBENEWSWIRE
Collegium Announces Q4 and Full Year 2022 Preliminary Financial Results
06 Feb 2023 //
GLOBENEWSWIRE
Collegium Pharmaceutical Announces Proposed Convertible Senior Notes Offering
06 Feb 2023 //
GLOBENEWSWIRE
Collegium Provides 2023 Financial Guidance
04 Jan 2023 //
GLOBENEWSWIRE
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
22 Dec 2022 //
GLOBENEWSWIRE
Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference
22 Nov 2022 //
GLOBENEWSWIRE
Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022
20 Oct 2022 //
GLOBENEWSWIRE
Collegium Announces 11 Poster Presentations at PAINWeek 2022 National Conference
30 Aug 2022 //
GLOBENEWSWIRE
Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022
21 Jul 2022 //
GLOBENEWSWIRE
Collegium to Participate in H.C. Wainwright Global Investment Conference
17 May 2022 //
GLOBENEWSWIRE
Collegium Reports First Quarter 2022 Financial Results
10 May 2022 //
GLOBENEWSWIRE
Collegium to Host Conference Call to Discuss 1 Q 2022 Financial Results
26 Apr 2022 //
GLOBENEWSWIRE
Collegium to Participate in Upcoming Needham Healthcare Conference
07 Apr 2022 //
GLOBENEWSWIRE
Collegium Provides 2022 Financial Guidance
05 Apr 2022 //
GLOBENEWSWIRE
Collegium`s Master Settlement Agreement Resolving Pending Opioid Litigation
30 Mar 2022 //
GLOBENEWSWIRE
Collegium Completes the Acquisition of BDSI
22 Mar 2022 //
GLOBENEWSWIRE
Collegium Reports Fourth Quarter and Full-Year 2021 Financial Results
24 Feb 2022 //
GLOBENEWSWIRE
Collegium Purchases BioDelivery Sciences International in All-Cash Deal
15 Feb 2022 //
CONTRACTPHARMA
Collegium to Host Conference Call to Discuss Q4 and Full-Year 2021 Results
10 Feb 2022 //
GLOBENEWSWIRE
Avenge Bio uncloaks with $45M and a slate of immunotherapies
05 Jan 2022 //
ENDPTS
Collegium Pharma Reaches Opioid Settlement with U.S. Government
29 Dec 2021 //
BIOSPACE
Collegium Announces $25 Million Accelerated Share Repurchase Program
15 Nov 2021 //
GLOBENEWSWIRE
Collegium to Host Conference Call to Discuss 3Q 2021 Financial Results
21 Oct 2021 //
GLOBENEWSWIRE